You are here

SARC016

Active
SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
Type of Sarcoma: 
Malignant Peripheral Nerve Sheath Tumor (MPNST) either Sporadic or NF1 Associated
Drug: 
Bevacizumab and Everolimus
Accrual Status: 
Ongoing,Not Accruing
Overall Study Principal Investigator: 

Brigitte Widemann, MD
Senior Investigator, Pediatric Oncology Branch
National Cancer Institute

For more information about this trial and open sites: